Efficient dosage regimen for introduction of warfarin treatment after coronary artery bypass grafting in Japanese patients

• KAWANA Junichi

  Department of Biopharmaceutics & Clinical Pharmacokinetics, Meiji Pharmaceutical University

• KOYANAGI Toshiya

  Department of Cardiology, Sakakibara Heart Institute, Japan Research Promotion Society for Cardiovascular Diseases

• SUMIYOSHI Tetsuya

  Department of Cardiovascular Surgery, Japanese Red Cross Kumamoto Hospital

• HANADA Kazuhiko

  Department of Biopharmaceutics & Clinical Pharmacokinetics, Meiji Pharmaceutical University

• OHNO Tetsuo

  Department of Pharmacy, Sakakibara Heart Institute, Japan Research Promotion Society for Cardiovascular Diseases

• OGATA Hiroyasu

  Department of Biopharmaceutics & Clinical Pharmacokinetics, Meiji Pharmaceutical University

収録刊行物

• 日本冠疾患学会雑誌 = Journal of the Japanese Coronary Association

  日本冠疾患学会雑誌 = Journal of the Japanese Coronary Association 15 (2), 98-103, 2009-06-25

キーワード

• warfarin
• anticoagulant therapy
• coronary artery bypass

詳細情報

• CRID: 1571135651017923328
• NII論文ID: 10026256552
• NII書誌ID: AA11155536
• ISSN: 13417703
• Web Site: https://search.jamas.or.jp/link/ui/2009345576
• 本文言語コード: en
• データソース種別:
  • CiNii Articles